Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
74
datasets available to search
ShareScore release 0.9.0
Dataset results
74 results for “essential thrombocythemia”
Hematopoietic Stem Cell Heterogeneity in JAK2 V617F+ Essential Thrombocythemia
GEO Series GSE111410. Homo sapiens. 22 samples. Type: Expression profiling by high throughput sequencing.
COMPARATIVE ANALYSIS OF LABORATORY PARAMETERS OF HEMATOPOIESIS AND HEMOSTATIC STATUS IN PATIENTS WITH POLYCYTHEMIA AND ESSENTIAL THROMBOCYTHEMIA.
Open the record for dataset details and reuse information.
Anagre Cap. in Patients With High-Risk Essential Thrombocythemia
ClinicalTrials.gov study NCT03232177. IPD Sharing: NO. Countries: 1. Publications: 0.
Anagrelide Retard in Essential Thrombocythemia
ClinicalTrials.gov study NCT02076815. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia
ClinicalTrials.gov study NCT05395507. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly
ClinicalTrials.gov study NCT01692366. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)
ClinicalTrials.gov study NCT04262141. IPD Sharing: NO. Countries: 1. Publications: 0.
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
ClinicalTrials.gov study NCT01420783. IPD Sharing: Not stated. Countries: 9. Publications: 0.
Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients
ClinicalTrials.gov study NCT01970930. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis
ClinicalTrials.gov study NCT02871323. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
ClinicalTrials.gov study NCT06456346. IPD Sharing: YES. Countries: 23. Publications: 0.
Identification of Factors Associated With Treatment Response in Patients With Polycythemia Vera, Essential Thrombocythemia, and Pre-myelofibrosis.
ClinicalTrials.gov study NCT05440838. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
ClinicalTrials.gov study NCT06079879. IPD Sharing: YES. Countries: 24. Publications: 0.
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia
ClinicalTrials.gov study NCT04226950. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
ClinicalTrials.gov study NCT06516406. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis
ClinicalTrials.gov study NCT01433445. IPD Sharing: NO. Countries: 5. Publications: 0.
A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed
ClinicalTrials.gov study NCT06343805. IPD Sharing: NO. Countries: 1. Publications: 0.
CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia
ClinicalTrials.gov study NCT03972943. IPD Sharing: NO. Countries: 1. Publications: 0.
Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)
ClinicalTrials.gov study NCT01236638. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Gene and miRNA expression profiles in Polycythemia Vera and Essential Thrombocythemia according to CALR and JAK2 mutations [GEP]
GEO Series GSE103237. Homo sapiens. 65 samples. Type: Expression profiling by array.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.